Dashengda and Tuopai Shede Group set up investment partnerships. According to the enterprise search APP, Sichuan Fujiang Yingke Investment Partnership (Limited Partnership) was recently established with a capital contribution of 200 million yuan. Its business scope includes: asset management services invested by its own funds; Enterprise management consulting; Information technology consulting service. Enterprise equity penetration shows that the enterprise is jointly held by Dashengda and Sichuan Tuopai Shede Group Co., Ltd..IEA Monthly Report: The daily output of the refinery will reach the annual peak of 84.3 million barrels in December. It is estimated that in 2024, the daily output of the refinery will increase by 520,000 barrels to an average of 82.7 million barrels per day. It is estimated that in 2025, the daily output of refineries will increase by 620,000 barrels to an average of 83.3 million barrels per day.Qianjin Pharmaceutical Co., Ltd.: The subsidiary company obtained the dapoxetine hydrochloride Pharmaceutical Registration Certificate, and Qianjin Pharmaceutical announced that Qianjin Xiangjiang Pharmaceutical Co., Ltd. received the dapoxetine hydrochloride Pharmaceutical Registration Certificate approved and issued by National Medical Products Administration. The medicine is suitable for the treatment of male premature ejaculation patients aged 18 to 64.
Lingang Daya Auto Parts Intelligent Manufacturing Base Project officially started. On the morning of December 12th, the groundbreaking ceremony of Lingang Daya Auto Parts Intelligent Manufacturing Base Project was held in Shanghai Lingang Fengxian Park. After the completion of the project, two 3500T/2500T high-speed multi-position stamping lines are designed, with an annual production capacity of 11 million pieces; Design 210 connection workstations such as spot welding/arc welding/projection welding/riveting, with an annual production capacity of 4 million sets of sheet metal parts; Design an intelligent logistics and three-dimensional warehouse.In the latest centralized purchase of sitagliptin tablets, the price dropped to less than 20 cents per tablet, with a drop of over 90%. The reporter learned at the scene of the tenth batch of drug centralized purchase that more than 30 companies bid for sitagliptin, which is known as the largest variety in this centralized purchase, including Huahai Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, tonghua dongbao, Zhejiang Pharmaceutical, Jiudian Pharmaceutical, Shiyao Ouyi, Chenxin Pharmaceutical and many other companies. Judging from the bidding results, the lowest bid price among enterprises has dropped below 0.2 yuan per piece, which is more than 90% lower than the limit price. Statistics show that in 2023, the sales of this product in the terminals of public medical institutions in China exceeded 2 billion yuan, and the sales of Merck, the original research manufacturer, accounted for more than 90%, so there is a large room for generic drug substitution. The quotation of Meradong in this collection is about 7.37 yuan per piece. (science and technology innovation board Daily)Mengke Pharmaceutical Co., Ltd.: The new packaging of Contizontamide tablets will be on the market soon. Mengke Pharmaceutical Co., Ltd. announced that the company has launched Contizontamide tablets with new packaging specifications, and a box of 12 tablets will be on the market soon. Contizontamide tablet is a new class 1 oxazolidinone antibacterial drug with global intellectual property rights. It was approved by National Medical Products Administration, China on June 1st, 2021 for the treatment of complex skin and soft tissue infections.
Ai Kelan: Liu Yi, the actual controller, intends to transfer 5% of the company's shares by agreement, with a total transaction price of 82.44 million yuan. Liu Yi, the controlling shareholder and actual controller, signed a share transfer agreement with Guangdong Nanchuan Private Equity Fund Management Co., Ltd., and Liu Yi intends to transfer 4 million unrestricted shares of the company (accounting for 5% of the company's total share capital) to Nanchuan Private Equity through agreement transfer. The transfer price is 20.61 yuan per share, and the total transaction price is 82.44 million yuan. This change in equity will not lead to changes in the controlling shareholder or actual controller of the company, and will not lead to changes in the control rights of listed companies.Jingzhou, Hubei Province reported that a large drone fell: the drone crashed into a structure out of control during the test and caught fire, and one person was injured. On December 12, the emergency service center of Jingzhou Economic Development Zone, Hubei Province issued a briefing. At 11: 10 on the 12 th, a company was testing a fixed-wing drone, and the drone crashed into the structure and caught fire. At present, the fire has been put out, and one injured person is being fully treated. The cause of the accident is under investigation.IEA Monthly Report: The decision of OPEC+has reduced the potential oversupply. The International Energy Agency (IEA) said today that the recent decision of OPEC+member countries to postpone the planned production increase has "greatly reduced" the potential oversupply next year. Nevertheless, IEA said that in view of the persistent overproduction in some OPEC+member countries, strong supply growth outside the alliance and moderate global oil demand growth, there may still be a serious oversupply in the oil market in 2025. IEA predicts that even if all OPEC+production reduction plans remain unchanged, supply will exceed demand by about 950,000 barrels per day next year. IEA said that if OPEC members start increasing production in April as planned, the oversupply will increase to 1.4 million barrels per day.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14